GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 768 filers reported holding GLAXOSMITHKLINE PLC in Q4 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $434,400,000 | -0.4% | 9,979,321 | -0.3% | 0.51% | +0.4% |
Q1 2022 | $436,119,000 | -3.3% | 10,011,921 | -2.1% | 0.51% | -8.7% |
Q4 2021 | $450,941,000 | +25.4% | 10,225,421 | +8.6% | 0.56% | +20.6% |
Q3 2021 | $359,725,000 | -0.3% | 9,414,421 | +3.9% | 0.46% | +3.3% |
Q2 2021 | $360,822,000 | +15.4% | 9,061,321 | +3.4% | 0.45% | +15.7% |
Q1 2021 | $312,752,000 | -40.4% | 8,763,021 | -38.6% | 0.39% | -31.8% |
Q4 2020 | $525,188,000 | -23.9% | 14,271,421 | -22.1% | 0.57% | -17.3% |
Q3 2020 | $689,928,000 | -17.7% | 18,329,654 | -10.8% | 0.69% | -4.8% |
Q2 2020 | $838,286,000 | -4.1% | 20,551,254 | -10.9% | 0.72% | -14.7% |
Q1 2020 | $874,367,000 | -2.2% | 23,076,454 | +21.3% | 0.85% | +23.6% |
Q4 2019 | $894,107,000 | +19.4% | 19,027,599 | +8.4% | 0.69% | +8.4% |
Q3 2019 | $749,107,000 | +22.6% | 17,551,699 | +15.0% | 0.63% | +17.8% |
Q2 2019 | $610,776,000 | +2.4% | 15,261,781 | +6.9% | 0.54% | -0.7% |
Q1 2019 | $596,452,000 | +34.1% | 14,272,600 | +22.6% | 0.54% | +11.3% |
Q4 2018 | $444,856,000 | +9.3% | 11,642,400 | +14.9% | 0.49% | +16.2% |
Q3 2018 | $407,131,000 | -41.3% | 10,135,200 | -41.9% | 0.42% | +10.8% |
Q2 2018 | $693,035,000 | +118.6% | 17,442,200 | +115.0% | 0.38% | +8.9% |
Q1 2018 | $316,967,000 | -7.6% | 8,112,800 | -16.1% | 0.35% | -8.2% |
Q4 2017 | $342,935,000 | -10.5% | 9,668,300 | +2.4% | 0.38% | -16.2% |
Q3 2017 | $383,171,000 | -4.8% | 9,437,700 | +1.1% | 0.45% | -12.3% |
Q2 2017 | $402,655,000 | +117.0% | 9,338,000 | +112.1% | 0.51% | +98.5% |
Q1 2017 | $185,593,000 | +56.2% | 4,402,100 | +42.7% | 0.26% | +37.8% |
Q4 2016 | $118,823,000 | +196.2% | 3,085,500 | +231.8% | 0.19% | +164.8% |
Q3 2016 | $40,111,000 | +81.2% | 930,000 | +82.1% | 0.07% | +69.0% |
Q2 2016 | $22,138,000 | +13.6% | 510,800 | +6.3% | 0.04% | +13.5% |
Q1 2016 | $19,488,000 | +173.8% | 480,600 | +172.4% | 0.04% | +131.2% |
Q4 2015 | $7,118,000 | -87.1% | 176,400 | -87.7% | 0.02% | -87.8% |
Q3 2015 | $55,007,000 | -59.3% | 1,430,600 | -55.9% | 0.13% | -57.5% |
Q2 2015 | $135,200,000 | +12.1% | 3,246,100 | +24.2% | 0.31% | +19.8% |
Q1 2015 | $120,571,000 | -53.0% | 2,612,600 | -56.5% | 0.26% | -58.5% |
Q4 2014 | $256,731,000 | -18.2% | 6,006,800 | -12.0% | 0.62% | -27.8% |
Q3 2014 | $313,865,000 | -33.8% | 6,827,600 | -23.0% | 0.86% | -22.3% |
Q2 2014 | $474,336,000 | +26.6% | 8,869,400 | +26.5% | 1.11% | +23.2% |
Q1 2014 | $374,534,000 | +9.2% | 7,009,800 | +9.1% | 0.90% | +9.4% |
Q4 2013 | $343,031,000 | +75.7% | 6,425,000 | +65.1% | 0.82% | +73.2% |
Q3 2013 | $195,227,000 | +187.8% | 3,891,300 | +186.7% | 0.47% | +166.3% |
Q2 2013 | $67,834,000 | – | 1,357,500 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |